THE EFFECT OF ADMINISTERING AFRICAN BITTER LEAF EXTRACT ON SPERMATOGENIC CELLS OF HYPERGLYCEMIC WISTAR RATS by Kartana, Kartana et al.




THE EFFECT OF ADMINISTERING AFRICAN BITTER LEAF EXTRACT ON 
SPERMATOGENIC CELLS OF HYPERGLYCEMIC WISTAR RATS 




Introduction: Diabetes is still a world health problem that can cause many complications. 
Male infertility is one of the diabetic complications. This condition is caused by oxidative 
stress in diabetic patients. African bitter leaf is believed to contain an antioxidant compound 
that can repair male infertility.  
Purpose: This study aims to determine the effect of administering African bitter leaf extract 
on spermatogenic cell count in hyperglycemic Wistar rats.  
Method: This study use Rattus norvegicus as an animal model, which was administrated with 
alloxan to induce hyperglycemic. P0 group were given Na CMC 0,1%, Control group were 
given glibenclamide 0,63/kg bodyweight for 14 days. 100mg/kg bodyweight (P1), 200mg/kg 
(P2), and 400mg/kg (P3) of African bitter leaf extract  were administrated for 14 days. In the 
end, the animals were sacrificed, and testicle histopathologic sections were made.  
Results: Significant result (P<0,05) comparing spermatogonium, primary spermatocyte, and 
spermatid count between groups. Post-hoc test shows the significant result on comparison of 
primary spermatocyte and spermatid count between P0 and P1. 
Conclusions: There is an effect of bitter leaf extract administration on spermatogenic cell 
count in hyperglycemic Wistar rats. The best improvement can be observed in the P1 group, 
administered with 100mg/kg bodyweight African bitter leaf. 
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Diabetes is still a world health problem, 
including in Indonesia1. Diabetes can cause 
complications, such as impairment of 
spermatogenesis in male2. Decrease of 
Follicle Stimulating Hormone (FSH) and 
Luteinizing hormone (LH), increase in the 
amount of Reactive Oxygen Species (ROS) 
and Advanced Glycation End Products 
(AGEs) in hyperglycemic condition 
causing oxidative stress that impairs 
spermatogenesis in diabetic male3. A 
cohort study in 1994-2012 shows that 
18.499 of 39.516 diabetic males 
experience infertility4. 
African bitter leaf (Vernonia 
amygdalina) is believed to contain 
antihyperglycemic and antioxidant effects. 
African bitter leaf is scrub. It grows in 
tropical areas such as Africa and 
Indonesia. It belongs to the family 
Asteraceae.  People use African bitter leaf 
for the side dish, and it contains 
antibacterial, anti-inflammation, 
antifungal, antimalarial, anti-cancer, anti-
hyperlipidemic effect, and etc5–7.  
African bitter leaf has antioxidant 
components (flavonoid, alkaloid, steroid, 
phenolic acid, saponin, tannin, 
sesquiterpene lactone). Those can stabilize 
free radicals to a more stable structure, 
chelating with metals and suppress pro-
oxidant enzyme8. 
According to this theory, we'd like to 
study the potential of African bitter leaf in 
male fertility. Therefore, it can be used as 
an alternative treatment for diabetic male 
infertility. This study aims to determine the 
effect of administering  African bitter leaf 




The materials used in this study were an 
ethanolic extract of African bitter leaf, 
CMC Na 0,1%. The ethanolic extract is 
given orally using oral gavage once daily.  
 
Animal 
The experimental animals used were white 
male rats (Rattus norvegicus). The 
experimental animals used were 2-3 
months old with 150-250 grams 
bodyweight as many as 31 animals. The 
animals were adapted to the environment 
for a week and placed in a cage containing 
two rats, each separated by wire. 
Male Wistar rats were divided 
randomly into five groups, Control group 
(K) that were induced to hyperglycemic 
condition and given Glibenclamide 
0,63mg/kg BW/day, Treatment group 0 
(P0) that were induced to hyperglycemic 
condition and given CMC Na 0,1% 
0,7ml/day, Treatment group 1 (P1) that 
were induced to hyperglycemic condition 
and given an ethanolic extract of African 




bitter leaf 100mg/kg BW/day, Treatment 
group 2 (P2) that were induced to 
hyperglycemic condition and given an 
ethanolic extract of African bitter leaf 
200mg/kg BW/day, and Treatment group 3 
(P3) that were induced to hyperglycemic 
condition and given an ethanolic extract of 
African bitter leaf 400mg/kg BW/day,  
 
Experimental procedures 
In this study, rats were induced to 
hyperglycemic conditions by administering 
a single dose of intraperitoneal injection 
alloxan monohydrate 150mg/kg BW. The 
rats would be given the treatment for 14 
days if, after four days of alloxan 
administration, the blood glucose level is 
above 200mg/dL. The rats would be 
sacrificed by anesthesia using ketamine-
xylazine and cervical dislocation. The 
testicle will be made into histopathological 
sections and observed with a light 
microscope.  
 
Spermatogenic Cell Counts 
Spermatogenic cell counts were done using 
a light microscope with 400x zoom. 
Spematogonium, primary spermatocyte, 
and spermatid were counted by the average 
cell counts in 5 random fields of view.  
 
Data Analysis 
Data obtained from this study were tested 
for normality with the Shapiro-Wilk test 
and homogeneity by Levene’s test. If the 
normality and homogeneity results show 
normal and homogenous data, the ANOVA 
test and Bonferroni (posthoc test) are used 
for the hypothesis test. Data shows 
significant if P < 0,05. 
 
RESULTS 
 The histopathological section of 
seminiferous tubule from the experimental 



















Figure 1. Histopathological section of 
seminiferous tubule from the experimental 
animals observed with a light microscope 
with 400x zoom. Spermatogonia (blue 
arrow), primary spermatocyte (red arrow), 
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A comparison of spermatogenic cell count 
is described in table 1. In this study, the 
hypothetical test is conducted using 
ANOVA and continued with the posthoc 
test Bonferroni. ANOVA test, which 
compares all groups (K: P0:P1:P2:P3), 
shows significant results. It means that 
there are differences in spermatogenic cell 
count (spermatogonia, primary 
spermatocyte, and spermatid) between 
treatment groups. P0 group has the lowest 
average cell count compared to other 
groups [Table 1]. 
 Post-hoc test using Bonferroni shows 
insignificant results compared to 
spermatogonium [Table 2] but shows 
significant results in comparison of 
primary spermatocyte and spermatid 
between P0 and P1 [Table 3 and 4].  
 
Table 1. Comparison of spermatogenic 
(spermatogonia, primary spermatocyte, and 













































Table 2. Hipothetical test of spermatogonia 
cell count between groups 
Group P (<0,05) 
K : P0 : P1 : P2 : P3 0,047* 
K : P0 1,000** 
K : P1 1,000** 
K : P2 1,000** 
K : P3 1,000** 
P0 : P1 0,074** 
P0 : P2 0,674** 
P0 : P3 1,000** 
P1 : P2 1,000** 
P1 : P3 0,156** 
P2 : P3 1,000** 
*   : Statistically significant 
** : Statistically insignificant 
 
Table 3. Hipothetical test of primary 
spermatocyte cell count between groups 
Group P (<0,05) 
K : P0 : P1 : P2 : P3 0,043* 
K : P0 1,000** 
K : P1 1,000** 
K : P2 1,000** 
K : P3 1,000** 
P0 : P1 0,038* 
P0 : P2 0,325** 
P0 : P3 1,000** 
P1 : P2 1,000** 
P1 : P3 0,501** 
P2 : P3 1,000** 
*   : Statistically significant 











Table 4. Hipothetical test of spermatid cell 
count between groups 
Group P (<0,05) 
K : P0 : P1 : P2 : P3 0,008* 
K : P0 0,492** 
K : P1 0,450** 
K : P2 1,000** 
K : P3 1,000** 
P0 : P1 0,004* 
P0 : P2 0,197** 
P0 : P3 0,888** 
P1 : P2 1,000** 
P1 : P3 0,239** 
P2 : P3 1,000** 
*   : Statistically significant 




This study is determined to compare 
spermatogenic cell count in alloxan-
induced hyperglycemic Rattus norvegicus 
and given glibenclamide (K), CMC Na 
0,1% (P0), ethanolic extract of African 
bitter leaf 100mg/kgbw (P1), 200mg/kgbw 
(P2), 400mg/kgbw (P3) for 14 days. 
Diabetes causes impairment in male 
fertility by interfering with LH & FSH 
secretion, increasing ROS production from 
the polyol-sorbitol pathway, AGEs 
formation, and protein kinase C. This will 
cause a decrease in testosterone hormone 
level, an increase in sperm DNA damage, 
and sperm apoptosis3,9.  
A previous study showed that a certain 
amount of African bitter leaf extract could 
increase spermatogenic cell count, repair 
seminiferous tubule microarchitecture, and 
increase the live death ratio of sperm10.  
African bitter leaf contains an alkaloid, 
flavonoid, saponin, tannin, steroid, and 
sesquiterpene lactone, which contain 
antioxidant activity by preventing free 
radical formation, suppressing pro-oxidant 
enzymes, and stimulating antioxidant 
enzymes11,12. 
African bitter leaf extract can lower 
blood glucose level by regenerating 
pancreatic β-cell which secrete insulin, 
suppressing serum caspase-3 which cause 
apoptosis of pancreatic β-cell and increase 
Glucose Transporter-2 (GLUT-2) 
expression which gives the signal to 
secrete insulin5,13. 
ANOVA test shows significant result in 
comparison of spermatogenic cell count 
between all groups, which means that there 
are differences in spermatogenic cell count 
(spermatogonia, primary spermatocyte, 
and spermatid) 
The posthoc test shows insignificant 
results in comparison to spermatogonia 
cell count. This may happen because 
spermatogonia have the highest amount of 
Superoxide Dismutase enzyme, which has 
antioxidant activity. So, spermatogonia 
have the highest tolerance level to 
oxidative stress14. Although the posthoc 
test shows an insignificant result, there is 
an increased average cell count in P1, P2, 
P3, and K groups compared to P0. 
The Effect of Administering African…  Kartana, Tahalele PL, Suwasanti N  
 
145 
P0 group has the lowest spermatogenic 
cell count, showing the damage of 
spermatogenic cells because of oxidative 
stress. Administration of African bitter leaf 
extract in the P1, P2, and P3 groups cause 
improvement in spermatogenic cell count 
compared to P0. P1 shows the closest cell 
count compared to normal rats. This result 
is in line with a previous study by Saalu et 
al. 10.  
Improvement of spermatogenic cell 
count in P2 and P3 is not as good as P1. 
This may be caused by alkaloid 
bioactivation in a larger dosage—the 
bioactivation cause released metabolites 
which cause DNA cross-link, cytotoxicity 
and increasing pro-oxidant activity15.  
 
CONCLUSION 
Based on this research, it is concluded that 
there are differences in spermatogenic cell 
count of hyperglycemic rats administered 
with African bitter leaf extract 100mg/kg 
BW, 200mg/kg BW, dan 400mg/kg BW 
for 14 days. Administration of 100mg/kg 
BW ethanolic bitter leaf extract shows the 
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